Spravato®, which is an esketamine nasal spray, has shown positive results in helping mental health conditions, but does Spravato® help with anxiety specifically? It is currently FDA-approved for treatment-resistant depression and major depressive disorder, but not specifically for Generalized Anxiety Disorder (GAD) as a standalone condition. However, studies have shown that ketamine-infusion therapy may help with generalized anxiety disorder and showed benefits for reducing panic, irritability, and other anxiety symptoms in people with Generalized Anxiety Disorder.
Low-dose ketamine infusion may be helpful for patients with anxiety who don’t respond to usual treatments, with the advantage that it’s quickly evident whether the patient will benefit. However, clinical research remains inconclusive about ketamine therapy for some anxiety conditions, like panic disorder. If you’re considering this treatment for GAD, it’s essential to discuss it with a qualified psychiatrist who can evaluate whether it might be appropriate for your specific situation.
Is Spravato® Approved by the FDA for Generalized Anxiety Disorder?
The FDA has not approved Spravato® specifically for generalized anxiety disorder or any other anxiety disorders as standalone conditions. However, the use of Spravato® for GAD would be considered “off-label” prescribing, where a doctor prescribes an FDA-approved medication for a condition other than what it was specifically approved to treat. Before using Spravato® for anxiety treatment, you’d need to discuss this with a psychiatrist who could evaluate whether off-label use might be appropriate for your specific situation, weighing the potential benefits against the risks and considering other available treatment options.
Why Do Some Doctors Use Spravato® Off-Label for Anxiety Disorders?
Some doctors use Spravato® off-label for anxiety disorders for several key reasons:
- Unique Mechanism of Action: Unlike traditional antidepressants that affect serotonin or dopamine, Spravato® targets a different brain pathway, which plays a key role in mood regulation, cognitive flexibility, and fear processing. It works by blocking NMDA receptors in the brain, which can potentially address anxiety through an entirely different neurobiological pathway than conventional treatments.
- Treatment-Resistant Cases: This medication is not a first-line treatment for anxiety but a potential alternative option when traditional anxiety treatments have failed. Doctors may consider it for patients who haven’t responded to multiple trials of standard anxiety medications like SSRIs, SNRIs, or benzodiazepines.
- Rapid Action Potential: The glutamate system can produce faster changes than traditional neurotransmitter systems, potentially offering quicker relief for severe anxiety symptoms compared to conventional medications that may take weeks to show effects.
- Co-occurring Depression: Many patients with anxiety disorders also have depression. Since Spravato is proven effective for treatment-resistant depression, doctors may prescribe it when both conditions are present, with the hope that anxiety symptoms may also improve.
- Research Foundation: While not FDA-approved for anxiety, there is growing research on ketamine-based treatments for various anxiety disorders, providing some scientific rationale for its potential effectiveness.
Off-label use requires careful psychiatric evaluation, informed consent, and monitoring, and doctors must ensure patients understand both potential benefits and risks. Research findings have yet to delve deeper into the use of Spravato® for anxiety alone since it is an off-label use, so evidence is still limited compared to its approved uses.
Mental Health Treatment That Works
Call 949-625-0564What our customers are saying
How Does Spravato® Compare to Traditional Anxiety Medications?
Here’s how Spravato® compares to traditional anxiety medications across key dimensions:
Mechanism of Action
- Traditional medications (SSRIs/SNRIs): Target serotonin or norepinephrine systems
- Benzodiazepines: Enhance GABA activity to calm brain activity
- Spravato: Increases levels of glutamate, the most abundant chemical messenger in the brain, resulting in a greater impact on more brain cells at one time.
Speed of Action
- Traditional antidepressants: Are slow-acting and often take several weeks to show effects
- Benzodiazepines: Work within minutes to hours
- Spravato: Can show effects within hours to days, much faster than traditional antidepressants.
Administration & Setting
- Traditional medications: Taken at home as oral pills/capsules
- Spravato: Must be administered in a healthcare facility under medical supervision, requires an over two-hour monitoring period after each dose.
Side Effect Profiles
- SSRIs: Common side effects include insomnia or sleepiness, sexual dysfunction, and weight gain
- Benzodiazepines: Risk of dependence, sedation, cognitive impairment
- Spravato: Can cause excessive sedation when combined with benzodiazepines, plus dissociation, nausea, and other acute effects during treatment.
Treatment Position
- Traditional medications: First-line treatments for anxiety disorders
- Spravato: Considered when you have been suffering from anxiety that didn’t improve with talk therapy and classical medication treatment
Addiction Potential
- SSRIs/SNRIs: Generally low addiction risk (though withdrawal can occur)
- Benzodiazepines: High addiction potential with long-term use
- Spravato: DEA Schedule III controlled substance, and can become highly addictive
Insurance Coverage: Traditional anxiety medications are typically covered for anxiety disorders, while Spravato® would likely require off-label use justification for anxiety treatment, potentially affecting coverage.
What Are the Potential Benefits of Using Spravato® for Anxiety Symptoms?
One of the most significant potential benefits of using Spravato® for anxiety symptoms lies in its unique and rapid mechanism of action. Unlike traditional antidepressants, esketamine increases levels of glutamate, the most abundant chemical messenger in the brain, resulting in a greater impact on more brain cells at one time.
This rapid-acting treatment can improve symptoms for many patients within hours or days instead of the weeks or months common with traditional medications, which is particularly valuable for individuals suffering from severe, debilitating anxiety who need more immediate relief than what conventional treatments can provide.
By increasing glutamate between neurons, esketamine can potentially strengthen neural connections and reset communication pathways, opening the door to improved mood and cognitive function changes that could directly benefit anxiety sufferers whose symptoms often involve disrupted thought patterns and emotional regulation.
The potential for using ketamine-assisted therapy near Tustin, CA, in treating treatment-resistant anxiety represents another compelling benefit of Spravato® therapy. For patients who have exhausted traditional anxiety treatments without success, esketamine represents a significant advancement, offering rapid relief when traditional medications haven’t worked.
By modulating glutamate receptors in key brain regions, Spravato® is believed to help regulate mood and emotion, addressing anxiety through an entirely different neurobiological pathway than SSRIs, SNRIs, or benzodiazepines.
Does Spravato® Help With Anxiety? Key Takeaways
- Spravato® is not FDA-approved for generalized anxiety disorder or any standalone anxiety conditions.
- Unlike traditional anxiety medications that target serotonin, norepinephrine, or GABA systems, Spravato® works through the glutamate pathway by blocking NMDA receptors.
- While traditional antidepressants can take weeks or months to show effects, Spravato® may provide relief within hours to days.
- Spravato® requires administration in a healthcare facility under medical supervision, with mandatory monitoring periods of two or more hours after each dose.
- Doctors typically consider Spravato® for anxiety only when traditional treatments have failed, positioning it as a last-resort option rather than a first-line treatment.
Does Spravato® help with anxiety? If you’re curious about whether Spravato can be effective in alleviating anxiety symptoms, we encourage you to reach out to Moment of Clarity at 949-625-0564. Our knowledgeable team at our network of outpatient mental health centers in Southern California is ready to discuss the mechanisms behind Spravato® and how ketamine therapy in Southern California can be utilized in the treatment of anxiety disorders.
Resources
- National Library of Medicine – The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
- Healthline – Ketamine therapy is a new approach to treating anxiety, offering potentially fast-acting relief for those who haven’t found help with traditional methods.
- Spravato.com – What Is Spravato?
